GO:0007190 activation of adenylate cyclase activity: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007190 describes the biological process that initiates the activity of the inactive enzyme adenylate cyclase, converting ATP to cyclic AMP (cAMP).
• Adenylate cyclase activation can be triggered by calcium-independent calmodulin binding, as shown in purified enzyme systems.
• Forskolin and its derivatives are potent, direct activators of adenylate cyclase, with structure-activity relationships defining their efficacy.
• Cholera toxin activates adenylate cyclase by interacting with the nucleotide regulatory site, a classic example of toxin-driven cAMP elevation.
• Dopamine D1 receptor agonists differentially activate adenylate cyclase, linking GPCR signaling to this process.
• Adenylate cyclase activation can shift the phase of a circadian pacemaker, demonstrating its role in biological timing.
Description
The biological process defined by GO:0007190, activation of adenylate cyclase activity, is a central signaling event in cells that converts the inactive form of adenylate cyclase into an active enzyme capable of synthesizing cyclic AMP (cAMP) from ATP. This process is initiated by diverse stimuli, including calcium-independent calmodulin binding, direct pharmacological activators such as forskolin, and bacterial toxins like cholera toxin that interact with the nucleotide regulatory site. Understanding this activation step is fundamental because cAMP serves as a ubiquitous second messenger controlling metabolism, gene expression, and cell proliferation. Researchers study GO:0007190 to dissect how extracellular signals are transduced into intracellular responses, and to identify therapeutic targets for diseases ranging from cancer to neurological disorders. The process is also a model for understanding how G-protein coupled receptors (GPCRs) and their agonists differentially regulate enzyme activity. Given its broad impact, precise experimental models are needed to probe the activation mechanism, and this article outlines the genes, functions, and research methods relevant to GO:0007190.
activation of adenylate cyclase activity At A Glance
| GO ID | GO:0007190 |
|---|---|
| GO term | activation of adenylate cyclase activity |
| Ontology | biological_process |
| Synonym | adenylate cyclase activation; adenylate cyclase activator; adenylyl cyclase activation |
| Major function | Initiates the activity of inactive adenylate cyclase, leading to cAMP production |
| Definition source | QuickGO definition: Any process that initiates the activity of the inactive enzyme adenylate cyclase. |
| Related molecules | Calmodulin, forskolin, cholera toxin, dopamine D1 receptor agonists |
| Physiological role | Second messenger signaling, circadian rhythm phase shifting, GPCR signal transduction |
What Is GO:0007190?
According to the Gene Ontology, GO:0007190 (activation of adenylate cyclase activity) is defined as any process that initiates the activity of the inactive enzyme adenylate cyclase. In other words, it covers the molecular events that switch adenylate cyclase from a dormant to a catalytically active state, enabling the enzyme to convert ATP into cAMP. This process is distinct from the catalytic activity itself and from downstream cAMP signaling; it focuses specifically on the triggering step. Synonyms include adenylate cyclase activation, adenylate cyclase activator, and adenylyl cyclase activation.
Why Is activation of adenylate cyclase activity Important in Cell Biology?
Activation of adenylate cyclase activity is a pivotal control point in cellular signaling because it determines the rate of cAMP synthesis, which in turn regulates numerous downstream effectors such as protein kinase A and exchange proteins directly activated by cAMP. This process is essential for normal physiology, including circadian rhythm entrainment, and its dysregulation is implicated in diseases such as cancer, heart failure, and neurological disorders. Pharmacological agents like forskolin are widely used to manipulate this process experimentally, and toxins such as cholera toxin exploit it to cause disease. Therefore, understanding the mechanisms and regulation of GO:0007190 is critical for both basic research and therapeutic development.
• Controls cAMP levels, a universal second messenger in eukaryotic cells.
• Mediates signaling from GPCRs, including dopamine D1 receptors, affecting neuronal function.
• Is a target of bacterial toxins such as cholera toxin, linking to infectious disease.
• Plays a role in circadian rhythm regulation, as activation shifts the phase of a circadian pacemaker.
• Serves as a pharmacological target; forskolin and derivatives are used to probe cAMP pathways.
• Involved in calcium-independent signaling via calmodulin, highlighting diversity of activation mechanisms.
• Provides a model for comparing signal transduction with phospholipase C activation.
• Dysregulation can contribute to diseases like cancer and neurodegeneration, though specific links require further study.
• Essential for understanding hormone and neurotransmitter action in metabolic and neurological contexts.
• Key for developing drugs that modulate cAMP signaling in cardiovascular and CNS disorders.
What Happens During activation of adenylate cyclase activity?
Initiation by Calcium-Independent Calmodulin Binding
In simple terms: Calmodulin can turn on adenylate cyclase without needing calcium.
One mechanism for activation of adenylate cyclase is through calcium-independent binding of calmodulin. Kilhoffer et al. (1983) demonstrated that calmodulin activates adenylate cyclase in a calcium-independent manner, suggesting a direct protein-protein interaction that relieves inhibition or induces a conformational change. This pathway highlights that activation can occur independently of calcium signals, diversifying the triggers for cAMP production.
Direct Activation by Forskolin and Derivatives
In simple terms: Forskolin, a plant compound, directly switches on adenylate cyclase.
Forskolin is a diterpene that directly activates adenylate cyclase. Seamon et al. (1983) established structure-activity relationships for forskolin and its derivatives, showing that specific chemical features are required for activation. Sano et al. (1983) further demonstrated forskolin activation of adenylate cyclase in rat brain and testis, confirming its utility as a research tool. This direct activation bypasses receptor and G-protein requirements, making forskolin a valuable probe for studying the activation process.
Toxin-Induced Activation via Nucleotide Regulatory Site
In simple terms: Cholera toxin activates adenylate cyclase by modifying its regulatory site.
Cholera toxin activates adenylate cyclase through interaction with the nucleotide regulatory site. Flores et al. (1976) proposed that cholera toxin activates adenylate cyclase by interacting with the nucleotide regulatory site, leading to persistent activation. This mechanism involves ADP-ribosylation of the Gs alpha subunit, which locks the enzyme in an active state, illustrating how pathogens can hijack this process.
Receptor-Mediated Activation by Dopamine D1 Agonists
In simple terms: Dopamine-like drugs can activate adenylate cyclase through receptors.
Dopamine D1 receptor agonists differentially activate adenylate cyclase. Ryman-Rasmussen et al. (2005) showed that novel dopamine D1 receptor agonists vary in their ability to activate adenylate cyclase and induce receptor internalization, indicating that activation efficacy can be dissociated from other signaling outcomes. This receptor-mediated activation involves G-protein coupling and represents a key pathway in neurotransmission.
Activation by Molybdate and Other Agents
In simple terms: Molybdate can also turn on adenylate cyclase in laboratory conditions.
Richards et al. (1979) reported that molybdate activates adenylate cyclase, likely by interacting with regulatory components. This finding expanded the list of agents that can initiate activation, though the physiological relevance remains unclear. Such chemical activators are useful for dissecting the activation mechanism in vitro.
Role in Circadian Pacemaker Phase Shifting
In simple terms: Activating adenylate cyclase can reset the biological clock.
Eskin et al. (1983) demonstrated that adenylate cyclase activation shifts the phase of a circadian pacemaker, linking cAMP signaling to biological timing. This suggests that activation of adenylate cyclase is not only a biochemical event but also a regulator of circadian rhythms, with implications for sleep and metabolic disorders.
Key Genes Involved in GO:0007190 activation of adenylate cyclase activity
The following genes and proteins are directly involved in or regulate the activation of adenylate cyclase activity, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADCY1 | Adenylate cyclase isoform 1; catalyzes cAMP synthesis upon activation | Studied for calmodulin-dependent activation |
| ADCY2 | Adenylate cyclase isoform 2; activated by forskolin | Used in forskolin activation studies |
| ADCY3 | Adenylate cyclase isoform 3; involved in olfactory signaling | Potential model for receptor-mediated activation |
| ADCY5 | Adenylate cyclase isoform 5; regulated by calcium/calmodulin | Relevant to calcium-independent activation |
| ADCY6 | Adenylate cyclase isoform 6; widely expressed | Target for toxin studies |
| ADCY8 | Adenylate cyclase isoform 8; calmodulin-sensitive | Model for calmodulin activation |
| ADCY9 | Adenylate cyclase isoform 9; linked to metabolic traits | Potential disease association |
| GNAS | Gs alpha subunit; stimulates adenylate cyclase | Central to receptor-mediated activation |
| CALM1 | Calmodulin; activates adenylate cyclase calcium-independently | Key regulator |
| DRD1 | Dopamine D1 receptor; activates adenylate cyclase via Gs | Model for agonist efficacy |
| DRD5 | Dopamine D5 receptor; stimulates adenylate cyclase | Related to D1 signaling |
| GNAI1 | Gi alpha subunit; inhibits adenylate cyclase | Counter-regulatory role |
| PRKACA | cAMP-dependent protein kinase A; downstream effector | Readout of activation |
| CREB1 | Transcription factor activated by cAMP | Downstream reporter |
| ADCY10 | Soluble adenylate cyclase; activated by bicarbonate | Distinct activation mechanism |
| HTR4 | Serotonin receptor 4; activates adenylate cyclase | GPCR model |
| ADRB1 | Beta-1 adrenergic receptor; activates adenylate cyclase | Cardiac signaling model |
| ADRB2 | Beta-2 adrenergic receptor; activates adenylate cyclase | Asthma and cardiovascular research |
How Is activation of adenylate cyclase activity Regulated?
The activation of adenylate cyclase activity is tightly regulated by multiple mechanisms. G-protein coupled receptors (GPCRs) such as dopamine D1 receptors stimulate Gs, which in turn activates adenylate cyclase. Conversely, Gi-coupled receptors inhibit the enzyme, as reviewed in comparisons with phospholipase C activation. Calcium-independent calmodulin binding provides an additional layer of regulation. Bacterial toxins like cholera toxin covalently modify Gs to cause persistent activation. Pharmacological regulators include forskolin, which directly activates the enzyme, and molybdate, which activates in vitro. This complex regulation ensures that cAMP levels are precisely controlled in response to diverse signals.
activation of adenylate cyclase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GNAS | Cholera toxin action; McCune-Albright syndrome | Knock-in of constitutively active GNAS in cell lines |
| ADCY1 | Neurological disorders; circadian rhythm | KO and point-mutation models in neurons |
| DRD1 | Parkinson's disease; addiction | Overexpression and KO in dopaminergic neurons |
| ADCY5 | Metabolic traits; dyskinesia | Knock-in of patient mutations in mice |
| ADCY9 | Cardiometabolic risk | KO and overexpression in adipocytes |
Cholera and Toxin-Mediated Diseases
Cholera toxin activates adenylate cyclase by interacting with the nucleotide regulatory site, leading to excessive cAMP production in intestinal cells and severe diarrhea. This exemplifies how dysregulation of GO:0007190 can cause acute disease. Understanding this mechanism has been crucial for developing treatments for cholera.
Neurological and Psychiatric Disorders
Dopamine D1 receptor agonists differentially activate adenylate cyclase, and this signaling is implicated in motor control, reward, and cognition. Dysregulation of adenylate cyclase activation in the brain may contribute to conditions such as Parkinson's disease and schizophrenia, although direct evidence requires further study. Circadian rhythm disruption linked to adenylate cyclase activation may also affect mood disorders.
Cancer and Cell Proliferation
Constitutive activation of adenylate cyclase can elevate cAMP, which has complex roles in cancer, either promoting or inhibiting proliferation depending on cell type. While specific mutations in adenylate cyclase genes are rare, dysregulated GPCR signaling upstream of GO:0007190 is common in cancer. Forskolin and derivatives are used experimentally to probe these pathways.
Metabolic and Cardiovascular Diseases
Adenylate cyclase activation in adipose tissue and heart regulates lipolysis and contractility. Beta-adrenergic receptors activate adenylate cyclase, and their dysfunction is linked to heart failure and metabolic syndrome. However, direct evidence from the cited literature is limited, and further research is needed to establish causal roles.
From activation of adenylate cyclase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does calmodulin activate adenylate cyclase independently of calcium? | Point mutation of calmodulin-binding site in ADCY1 (KO/knock-in) |
| How does forskolin binding activate adenylate cyclase? | Overexpression of ADCY isoforms with tagged knock-in for structural studies |
| What is the role of Gs alpha in receptor-mediated activation? | GNAS knockout and conditional knock-in cell lines |
| How does cholera toxin modify adenylate cyclase activation? | Knock-in of ADP-ribosylation-resistant GNAS mutant |
| Does adenylate cyclase activation affect circadian rhythms? | Knockout of ADCY isoforms in circadian reporter cells |
| Can dopamine D1 agonists differentially activate adenylate cyclase? | DRD1 point mutations and overexpression in neuronal cells |
How to Study the activation of adenylate cyclase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| cAMP ELISA | Intracellular cAMP concentration | High-throughput screening of activators |
| Radioactive enzyme assay | Adenylate cyclase catalytic activity | Mechanistic studies of activation |
| Forskolin stimulation assay | Direct activation of adenylate cyclase | Pharmacological profiling |
| Receptor internalization assay | GPCR-mediated activation | Agonist efficacy studies |
| CRISPR knockout | Gene necessity for activation | Target validation |
| Western blot | Protein expression and phosphorylation | Pathway analysis |
| Circadian phase shift assay | Effect on biological clock | Rhythm research |
cAMP Accumulation Assays
Measuring intracellular cAMP levels is the most direct way to assess activation of adenylate cyclase. Forskolin-stimulated cAMP accumulation is a standard assay. Radioimmunoassays or ELISA-based kits are commonly used. This method quantifies the output of GO:0007190 and is suitable for high-throughput screening.
Enzyme Activity Assays
Direct measurement of adenylate cyclase enzymatic activity using radiolabeled ATP is a classic approach. Kilhoffer et al. (1983) used such assays to demonstrate calcium-independent activation by calmodulin. This method provides kinetic parameters and is ideal for mechanistic studies.
Receptor Binding and Internalization Studies
To study receptor-mediated activation, researchers can measure agonist-induced receptor internalization alongside cAMP production. Ryman-Rasmussen et al. (2005) used this approach to differentiate dopamine D1 agonists. Flow cytometry and imaging can quantify internalization.
Genetic Knockout and Knock-in Models
CRISPR-Cas9 can generate knockout cell lines for adenylate cyclase isoforms or G proteins to test their necessity in activation. Knock-in of point mutations can mimic disease-associated variants. These models are essential for causal inference.
How CRISPR Can Be Used to Study GO:0007190 activation of adenylate cyclase activity
Knockout
CRISPR knockout of adenylate cyclase isoforms (e.g., ADCY1, ADCY5) or GNAS can abolish activation of adenylate cyclase activity, allowing researchers to test which genes are essential for the process. For example, knocking out GNAS would prevent receptor-mediated activation. These models are valuable for target validation.
Point Mutation
Introducing point mutations in genes such as GNAS or ADCY isoforms can mimic disease-associated variants or disrupt specific regulatory sites. For instance, mutating the calmodulin-binding site in ADCY1 could test calcium-independent activation. Point mutations can also render Gs resistant to cholera toxin.
Knock-in
Knock-in of tagged adenylate cyclase (e.g., GFP-ADCY) allows live-cell imaging of enzyme localization and activation dynamics. Knock-in of reporter genes under cAMP-responsive promoters (e.g., CRE-luciferase) provides a sensitive readout of GO:0007190.
Overexpression
Overexpression of adenylate cyclase isoforms or constitutively active Gs can enhance activation and cAMP production, useful for studying downstream effects. However, overexpression may cause artifacts, so inducible systems are recommended. Forskolin can be used as a positive control.
How EDITGENE Supports activation of adenylate cyclase activity Research
Researchers studying activation of adenylate cyclase activity-related genes often need to determine whether a candidate gene is causally involved in the activation process or is merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation, from knockout to knock-in, ensuring rigorous experimental validation.
Contact EDITGENE today to design your custom CRISPR model for activation of adenylate cyclase activity research.
Frequently Asked Questions About activation of adenylate cyclase activity
What is activation of adenylate cyclase activity?
It is the biological process (GO:0007190) that initiates the activity of the inactive enzyme adenylate cyclase, leading to cAMP production.
What genes are involved in activation of adenylate cyclase activity?
Key genes include ADCY isoforms (e.g., ADCY1, ADCY5), GNAS, CALM1, and receptors like DRD1.
How is adenylate cyclase activated?
It can be activated by calcium-independent calmodulin binding, forskolin, cholera toxin, and GPCR agonists.
What is the role of forskolin in adenylate cyclase activation?
Forskolin directly activates adenylate cyclase, and its derivatives show structure-activity relationships.
How does cholera toxin activate adenylate cyclase?
Cholera toxin interacts with the nucleotide regulatory site, causing persistent activation.
Can adenylate cyclase activation affect circadian rhythms?
Yes, activation shifts the phase of a circadian pacemaker.
What diseases are linked to adenylate cyclase activation?
Cholera, neurological disorders, and potentially cancer and metabolic diseases.
How can I study activation of adenylate cyclase activity in the lab?
Use cAMP assays, enzyme activity assays, and CRISPR knockout models.
What CRISPR models are available for adenylate cyclase research?
Knockout, point mutation, knock-in, and overexpression models can be custom-generated.
Why is calcium-independent activation important?
It shows that calmodulin can activate adenylate cyclase without calcium, diversifying signaling mechanisms.
Conclusion
Activation of adenylate cyclase activity (GO:0007190) is a fundamental signaling process with broad implications for physiology and disease. From calmodulin and forskolin to cholera toxin and GPCR agonists, multiple mechanisms converge to switch on this enzyme and produce cAMP. Understanding these pathways is essential for developing therapeutics targeting cAMP signaling. EDITGENE provides the CRISPR tools needed to dissect the genetic basis of this process with precision.
References
- 1. Kilhoffer MC et al.. 1983. Calcium-independent activation of adenylate cyclase by calmodulin.. Eur J Biochem 133(1):11-5 PMID: 6303782
- 2. Eskin A et al.. 1983. Adenylate cyclase activation shifts the phase of a circadian pacemaker.. Science 220(4592):82-4 PMID: 6298939
- 3. Seamon KB et al.. 1983. Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives.. J Med Chem 26(3):436-9 PMID: 6681845
- 4. Ryman-Rasmussen JP et al.. 2005. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.. Mol Pharmacol 68(4):1039-48 PMID: 15985612
- 5. Richards JM et al.. 1979. Activation of adenylate cyclase by molybdate.. J Biol Chem 254(15):6857-60 PMID: 457657
- 6. Flores J et al.. 1976. The activation of adenylate cyclase by cholera toxin: possible interaction with the nucleotide regulatory site.. Ciba Found Symp PMID: 186240
- 7. Sano M et al.. 1983. Activation of adenylate cyclase by forskolin in rat brain and testis.. Arch Biochem Biophys 220(2):333-9 PMID: 6681696
- 8. Guillon G et al.. 1987. Mechanisms of phospholipase C activation: a comparison with the adenylate cyclase system.. Biochimie 69(4):351-63 PMID: 3115315
